Cytology and Biomarkers in NMIBC
Cystoscopy and cytology remain the standard for diagnosis, but a plethora of urinary biomarkers could someday be a useful adjunct to NMIBC surveillance.
Bladder Cancer
FEATURES
Latest Bladder Cancer News
Second Primary Cancers Less Likely With IMRT vs CRT for Prostate Tumors
Among patients receiving radiation therapy (RT) for prostate cancer, intensity-modulated radiation therapy is significantly associated with a reduced risk for second primary solid malignancies compared with 3D conformal RT.
Tislelizumab Shows Promise for High-Risk Nonmuscle-Invasive Bladder Cancer
Investigators observed a complete response in more than half of patients treated with tislelizumab plus nab-paclitaxel for high-risk NMIBC that was not completely resectable.
Novel Agent N-803 Safe, Effective for BCG-Unresponsive High-Risk NMIBC
Investigators sought to determine the efficacy and safety of N-803 plus BCG in patients with high-risk NMIBC.
Erectile Function Prior to Nerve-Sparing RC Affects Return to Potency
Men undergoing radical cystectomy are most likely to recover erectile function if they have good function before the surgery and receive nerve-sparing, according to investigators.
Adjuvant Nivolumab Shows Durable Benefit in High-Risk MIUC
Longer follow-up from the CheckMate 274 trial shows nivolumab given after radical surgery for high-risk muscle-invasive urothelial carcinoma maintains a clinically meaningful improvement in disease-free survival.
Cessation Program in Cancer Clinics May Reach More Tobacco Smokers
Low-burden, point-of-care program may increase access to and impact of treatment to assist tobacco cessation
Cancer Risks Increase With Albuminuria
In a Dutch study, each doubling of urine albumin excretion was significantly associated with a 7% increase in overall cancer risk.
Outcomes of Robotic, Open Cystectomy Compared in Bladder Cancer
Number of days alive and out of hospital within first 90 days greater for robot-assisted surgery, but clinical significance of findings unclear
Use of 5-ARIs May Decrease Bladder Cancer Risk
A study examined bladder cancer risk and mortality among nearly 100,000 men from Ontario, Canada, who received 5-alpha reductase inhibitors.
Predictors of Recurrence After RNU for Low-Grade UTUC
Findings may inform surveillance strategies and improve treatment outcomes.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Bladder Cancer
Loading... 
Loading...